Recursion Pharmaceuticals alternatives

5 Best Recursion Pharmaceuticals Alternatives for AI-Driven Drug Discovery

While Recursion leads in automated cellular imaging, specialized platforms are emerging for complex neurological and system-level therapeutics.

Written by Hustlin from public information. Exin Therapeutics hasn’t joined Hustlin.

Recursion Pharmaceuticals has set the standard for using computer vision and automated biology to screen compounds at scale. Their approach, known as phenomics, uses AI to identify how drugs affect cellular health. However, for researchers focused on complex organ systems like the brain, cellular models alone often lack the necessary context. This list explores alternatives that offer different data sources, from physics-based modeling to in-vivo neural mapping.

First, what is Recursion Pharmaceuticals?

Best for: Large-scale screening of compounds where cellular phenotypes are the primary indicator of success.

Strengths

  • Massive proprietary dataset of cellular images
  • Highly automated laboratory infrastructure
  • Broad pipeline covering rare diseases and oncology

Where it falls short

  • Reliance on cellular assays which may not translate to complex organ systems
  • High operational overhead as a large public company
  • Limited focus on real-time neural circuit dynamics

The top alternatives

  1. #1Top pick

    Exin Therapeutics: High-Throughput In-Vivo Neural Discovery

    Exin Therapeutics specializes in discovering drugs for neurological disorders by mapping neural activity in living systems. While many AI drug discovery firms rely on static cell cultures, Exin uses high-density multimodal mouse data to train their AI models. This allows them to observe how potential therapeutics modify brain activity in real-time, specifically targeting epilepsies, autism, and Parkinson’s disease.

    • Focus on in-vivo mouse studies rather than isolated cell cultures
    • AI models trained on high-density multimodal neural data
    • Founded by Oxford-trained neuroscientists with rapid execution cycles
    • Specialized in therapeutics that modify neural circuit dysfunction
    Try Exin Therapeutics
  2. #2Alternative

    Schrödinger

    A leader in physics-based software, Schrödinger uses computational chemistry to predict how molecules will bind to targets before they are synthesized in a lab.

    Best for: Precise molecular modeling and lead optimization.

  3. #3Alternative

    Insilico Medicine

    Insilico uses generative AI to identify new targets and design novel molecular structures, with several candidates already in clinical trials.

    Best for: End-to-end generative drug design and target discovery.

  4. #4Alternative

    Exscientia

    Exscientia focuses on a patient-first approach, using AI to analyze human tissue samples rather than relying solely on animal or cell models.

    Best for: Precision medicine and patient-centric drug design.

  5. #5Alternative

    Relay Therapeutics

    Relay combines computational tools with experimental techniques to observe protein motion, allowing them to target proteins previously considered undruggable.

    Best for: Targeting complex protein dynamics in oncology.

Side-by-side comparison

CategoryExin TherapeuticsRecursion PharmaceuticalsEdge
Primary Data SourceIn-vivo neural activity (Mouse)In-vitro cellular imaging (Phenomics)Stronger
Therapeutic FocusNeurology & Brain ActivityBroad (Oncology, Rare Disease)Neck-and-neck
Core TechnologyMultimodal AI + Neural MappingComputer Vision + RoboticsNeck-and-neck
Development SpeedRapid (Proof-of-concept in 1.5 months)Industrial scale (Years of pipeline)Stronger
Biological ContextSystem-level brain circuitsSingle-cell morphologyStronger
Company StageEarly-stage (Launched)Publicly traded (Clinical-stage)Stronger

Frequently asked questions

How does Exin Therapeutics differ from Recursion?

Recursion looks at how drugs change the appearance of cells in a dish. Exin looks at how drugs change the electrical and functional activity of the brain in living models.

Is Exin Therapeutics only for epilepsy?

While the initial focus is on epilepsy and Parkinson's, the platform is designed to address any neurological disorder caused by dysfunctional neural activity.

Advance Your Neuro-Therapeutic Pipeline

Partner with Exin Therapeutics to leverage high-throughput neural data for your next discovery.

View Exin Therapeutics on YC

Building something?

Create a free Hustlin account. Your first Ship Day includes a campus invite, a blog post, and social posts with real URLs.

Create your free account